KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Interest & Investment Income (2020 - 2021)

Ginkgo Bioworks Holdings filings provide 2 years of Interest & Investment Income readings, the most recent being $496000.0 for Q4 2021.

  • On a quarterly basis, Interest & Investment Income rose 116.63% to $496000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $952000.0, a N/A change, with the full-year FY2025 number at $22.6 million, down 41.43% from a year prior.
  • Interest & Investment Income hit $496000.0 in Q4 2021 for Ginkgo Bioworks Holdings, up from $121000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $3.3 million in Q3 2020 to a low of -$3.0 million in Q4 2020.